Your browser doesn't support javascript.
loading
Oligometastatic and oligoprogressive esophageal squamous cell carcinoma:clarifying conceptions and surgery perspectives / 中华外科杂志
Zhonghua Wai Ke Za Zhi ; (12): 122-127, 2022.
Article em Zh | WPRIM | ID: wpr-935589
Biblioteca responsável: WPRO
ABSTRACT
The oligometastatic and oligoprogressive state has been a hot issue in cancer research. Its indolent tumor behavior, representing a novel therapeutic opportunity, has been identified as a clinical subtype in several malignancies. However, the clinical implications of the oligometastatic and oligoprogressive state in esophageal squamous cell carcinoma (ESCC) have not been thoroughly elucidated. There are still controversies regarding the existence of the oligometastatic state in ESCC, if the solitary regional lymph node metastasis should be viewed as oligoprogressive disease after esophagectomy, and the role of surgery and radiotherapy in ESCC oligometastatic disease. Despite many exciting contributions to the literature on these, further exploration is warranted. Thus, fostering the advance of research and scientific knowledge on the biological and prognostic characteristics scrupulously would facilitate personalizing treatment strategy for better outcomes.
Assuntos
Texto completo: 1 Índice: WPRIM Assunto principal: Prognóstico / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Estudos Retrospectivos / Esofagectomia / Carcinoma de Células Escamosas do Esôfago / Estadiamento de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Assunto principal: Prognóstico / Neoplasias Esofágicas / Carcinoma de Células Escamosas / Estudos Retrospectivos / Esofagectomia / Carcinoma de Células Escamosas do Esôfago / Estadiamento de Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article